← Ticker index
EXAS
Ticker
EXAS
Congressional Trades
13
by 2 members
Ticker disclosure brief
Congressional disclosure records for EXAS
A ticker-first view of recent disclosures, reported ranges, filing lags, party aggregates, federal awards, lobbying records, and source-linked receipts.
Latest receipt
Kevin Hern
SELL · 2026-03-24
Largest range
$50K – $100K
Kevin Hern
Longest observed gap
35d
Josh Gottheimer
Highest 30d vs SPY
71.2%
Josh Gottheimer
Purchase rows
0
0%
Sale rows
11
85%
Disclosed midpoint
$171K
range estimate
Unique Traders
2
members
Disclosure timing method
Observed filing gaps are not notice-date findings
The reporting deadline is the earlier of 30 days after notice or 45 days after the transaction. Public disclosure rows provide transaction and filing dates, but do not establish when a member received notice. PoliWealth therefore marks only transaction-to-filing gaps over 45 days as an apparent delay for review; 31–45 day gaps are not labeled late from transaction date alone.
Party Breakdown
Democrats7 · 54%
Republicans6 · 46%
Federal awards
all →- 2026-06-22$127KDepartment of Veterans AffairsONCOTYPE DX TESTING - MODIFICATION TO ADD 52.222-90
- 2026-02-18$52KDepartment of Veterans AffairsONCOTYPE DX OY3
- 2026-01-22$24KDepartment of Veterans AffairsTASK ORDER IN SUPPORT OF OY1 - STL VAMC ONCOTYPE-DX TESTING SERVICES AWARD
- 2026-01-22$3KDepartment of Veterans AffairsTASK ORDER IN SUPPORT OF OY 1 - TOPEKA VAMC ONCOTYPE-DX TESTING SERVICES AWARD
- 2026-01-22$3KDepartment of Veterans AffairsTASK ORDER IN SUPPORT OF OY 1 - LEAVENWORTH VAMC ONCOTYPE-DX TESTING SERVICES AWARD
Lobbying filings
all →- 2026-04-20$400KEXACT SCIENCESHR 842/S 339 support Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act H.R. 7118 support Genomic Answers for Childrens Health Act Support colorectal cancer screening prevention standards Support patient access to cancer screening and diagnostics Support veteran access to guideline-recommended colorectal cancer screening
- 2026-04-20$75KEXACT SCIENCESMedicare Multi-Cancer Early Detection Screening Coverage Act Issues related to cancer screenings Expanding access to cancer screening
- 2026-04-19$60KEXACT SCIENCES CORPORATIONH.R. 842, S.339 The Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act H.R.7118 Genomic Answers for Children's Health Act H.R. 842, S.339 the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act H.R.7118 Genomic Answers for Children's Health Act FY27 MilCon-VA appropriations Access to colorectal cancer screening tests
- 2026-01-22$420KEXACT SCIENCESHR 842/S 339 support Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act. Support colorectal cancer screening standards Support patient access to cancer screening and diagnostics. Support HR 1780/S 642 Finn Sawyer Access to Cancer Testing Act Support S 1410 Find It Early Act Support HR 2921/S 2745 Federal Firefighter Cancer Detection and Prevention Act of 2025 Support HR 1610 FIRE Cancer Act Support HR 4752/S 2760 Reducing Hereditary Cancer Act Support HR 7714 Colorectal Cancer Early Detection Act Support S 1717 Ensuring Patient Access to Critical Breakthrough Products Act Support veteran access to guideline-recommended colorectal cancer screening.
- 2026-01-20$75KEXACT SCIENCESMedicare Multi-Cancer Early Detection Screening Coverage Act
- 2026-01-20$60KEXACT SCIENCES CORPORATIONH.R. 842, S.339 The Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act Issues related FDA regulation of laboratory tests H.R. 842, S.339 the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act FY26 MilCon-VA appropriations Access to colorectal cancer screening tests
- 2025-10-23$450KEXACT SCIENCESSupport veteran access to guideline-recommended colorectal cancer screening. HR 842/S 339 support Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act: This bill allows, beginning in 2028, for Medicare coverage and payment for multi-cancer early detection screening tests that are approved by the Food and Drug Administration and that are used to screen for cancer across many cancer types, if the Centers for Medicare & Medicaid Services determines such coverage is appropriate. Coverage is limited to those under a certain age (age 68 in 2028, increased by one year every year thereafter) and to one test every 11 months. Support patient access to cancer screening and diagnostics. Support HR 1780/S 642 Finn Sawyer Access to Cancer Testing Act Support S 1410 Find It Early Act Support HR 2921/S 2745 Federal Firefighter Cancer Detection and Prevention Act of 2025 Support HR 1610 FIRE Cancer Act Support HR 4752/S 2760 Reducing Hereditary Cancer Act Support HR 771
- 2025-10-20$75KEXACT SCIENCESMedicare Multi-Cancer Early Detection Screening Coverage Act H.R.842: Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act S.339: Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act Expanding access to cancer screening
- 2025-10-19$60KEXACT SCIENCES CORPORATIONH.R. 842, S.339 The Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act Issues related FDA regulation of laboratory tests H.R. 842, S.339 the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act FY26 MilCon-VA appropriations Access to colorectal cancer screening tests
- 2025-07-25$480KEXACT SCIENCESSupport legislative efforts to develop alternative diagnostics legislation in lieu of LDT rule. Support veteran access to guideline-recommended colorectal cancer screening. HR 842/S 339 support Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act: This bill allows, beginning in 2028, for Medicare coverage and payment for multi-cancer early detection screening tests that are approved by the Food and Drug Administration and that are used to screen for cancer across many cancer types, if the Centers for Medicare & Medicaid Services determines such coverage is appropriate. Coverage is limited to those under a certain age (age 68 in 2028, increased by one year every year thereafter) and to one test every 11 months.
Loading trade analytics…
All Disclosed Trades
Page 1 · 13 of 13 shown| Date | Member | Action | Amount | Observed Gap | Receipt |
|---|---|---|---|---|---|
| 2026-03-24 | RKevin Hern | SELL | $1K – $15K | 13d | receipt → |
| 2026-03-24 | RKevin Hern | SELL | $1K – $15K | 13d | receipt → |
| 2026-03-24 | RKevin Hern | SELL | $1K – $15K | 10d | receipt → |
| 2026-03-24 | RKevin Hern | SELL | $1K – $15K | 10d | receipt → |
| 2024-05-10 | DJosh Gottheimer | SELL | $1K – $15K | 29d | receipt → |
| 2024-05-10 | DJosh Gottheimer | SELL | $1K – $15K | 29d | receipt → |
| 2024-05-10 | DJosh Gottheimer | SELL | $1K – $15K | 26d | receipt → |
| 2024-02-01 | DJosh Gottheimer | SELL | $1K – $15K | 35d | receipt → |
| 2024-02-01 | DJosh Gottheimer | SELL | $1K – $15K | 35d | receipt → |
| 2024-02-01 | DJosh Gottheimer | PARTIAL_SELL | $1K – $15K | 33d | receipt → |
| 2024-01-02 | RKevin Hern | SELL | $1K – $15K | 1d | receipt → |
| 2023-11-13 | DJosh Gottheimer | PARTIAL_SELL | $1K – $15K | 22d | receipt → |
| 2022-12-19 | RKevin Hern | SELL | $50K – $100K | 1d | receipt → |
“Observed gap” is the calendar distance from transaction date to filing date; only gaps over 45 days receive an apparent-delay marker.